Treatment Opportunities for Colorectal Liver Metastases - European Medical Journal
×

Browse

Treatment Opportunities for Colorectal Liver Metastases

| Download as | PDF
Authors:
*Tormod Lund
Disclosure:

The author has declared no conflicts of interest.

Received:
05.02.16
Accepted:
10.03.16
Citation
EMJ. ;1[2]:76-83.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Colorectal liver metastases (CLM) are the most common hepatic malignancy and are caused by disseminated tumour cells (DTCs) seeded early in the tumourigenesis of colorectal cancer. Despite optimal treatment, CLM are associated with high mortality rates. This review provides an overview of three promising strategies to extend survival in CLM: treatment of DTCs, immunotherapy, and new surgical resection techniques.

Please view the full content in the pdf above.